Eledon Pharmaceuticals, Inc. (NVUS) [Rocket]

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Revenues	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross profit	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin	100.0%
Selling, general and administrative [+]	13.1	10.1	6.1	7.2	11.1	1.9	12.6	8.9
General and administrative	13.1	10.1	6.1	7.2	11.1	1.9	12.6	8.9
Research and development	23.7	6.1	8.1	6.8	2.0	3.2	32.6	14.6
Other operating expenses	36.9
EBITDA [+]		-16.2	-14.2	-14.0	-13.1	-5.1	-45.2	-23.4
EBITDA growth	113.7%	14.1%	0.9%	7.3%	157.2%	-88.7%	92.6%	48.9%
EBITDA margin	-88.3%
Depreciation and amortization		0.0	0.0	0.0	0.0	0.0	0.1	0.0
EBIT [+]	-34.6	-16.2	-14.2	-14.1	-13.1	-5.1	-45.3	-23.5
EBIT growth	113.6%	14.1%	0.9%	7.2%	155.9%	-88.7%	92.9%	49.0%
EBIT margin	-88.3%
Non-recurring items [+]	2.3	2.3	1.9
Asset impairment			1.9
Interest income							0.2	0.2
Interest income							0.2	0.2
Other income (expense), net	0.0	-4.8	0.0	0.0	0.0	-0.5
Pre-tax income	-36.9	-23.2	-16.0	-14.1	-13.1	-5.7	-45.1	-23.3
Income taxes	-2.4	-0.4	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	6.4%	1.7%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-34.5	-22.8	-16.0	-14.1	-13.1	-5.7	-45.1	-23.3
Net margin	-88.1%

Basic EPS [+]	($2.33)	($15.72)	($24.42)	($1.56)	($2.80)	($14.77)	($2.01)	($3.60)
Growth	-85.2%	-35.7%	1463.8%	-44.3%	-81.0%	636.8%	-44.3%	-90.5%
Diluted EPS [+]	($2.33)	($15.72)	($24.42)	($1.56)	($2.80)	($14.77)	($2.01)	($3.60)
Growth	-85.2%	-35.7%	1463.8%	-44.3%	-81.0%	636.8%	-44.3%	-90.5%

Shares outstanding (basic) [+]	14.8	1.5	0.7	9.0	4.7	0.4	22.5	6.5
Growth	921.0%	121.4%	-92.7%	92.5%	1122.1%	-98.3%	247.6%	1455.0%
Shares outstanding (diluted) [+]	14.8	1.5	0.7	9.0	4.7	0.4	22.5	6.5
Growth	921.0%	121.4%	-92.7%	92.5%	1122.1%	-98.3%	247.6%	1455.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.